Share

October 20, 2020; 95 (16) Article

Association of epileptiform abnormalities and seizures in Alzheimer disease

Alice D. Lam, Rani A. Sarkis, Kyle R. Pellerin, Jin Jing, Barbara A. Dworetzky, Daniel B. Hoch, Claire S. Jacobs, Jong Woo Lee, Daniel S. Weisholtz, Rodrigo Zepeda, M. Brandon Westover, Andrew J. Cole, Sydney S. Cash
First published August 6, 2020, DOI: https://doi.org/10.1212/WNL.0000000000010612
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
617

Share

Article Information

vol. 95 no. 16 e2259-e2270
DOI: 
https://doi.org/10.1212/WNL.0000000000010612
PubMed: 
32764101
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received November 18, 2019
  • Accepted in final form May 14, 2020
  • First Published August 6, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Alice D. Lam, MD, PhD*,
    2. Rani A. Sarkis, MD, MSc*,
    3. Kyle R. Pellerin, BS,
    4. Jin Jing, PhD,
    5. Barbara A. Dworetzky, MD,
    6. Daniel B. Hoch, MD,
    7. Claire S. Jacobs, MD, PhD,
    8. Jong Woo Lee, MD, PhD,
    9. Daniel S. Weisholtz, MD,
    10. Rodrigo Zepeda, MD,
    11. M. Brandon Westover, MD, PhD,
    12. Andrew J. Cole, MD and
    13. Sydney S. Cash, MD, PhD
  1. Alice D. Lam, MD, PhD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) American Clinical Neurophysiology Society, funding for travel (hotel) to speak at annual ACNS 2020 annual meeting

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Empatica

    Research Support, Government Entities:

    1. 1) NIH - NINDS - K23 NS101037, PI, 2018-present 2) NIH - NIA - R21 AG064413, PI, 2019-present 3) NIH - NINDS - R25 NS065743, investigator on supplement, 2014-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) American Academy of Neurology - Susan Spencer Award

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Rani A. Sarkis, MD, MSc*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Serves on the editorial board of Epilepsy and Behavior.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. EEG reading for Digitrace

    Clinical procedures or imaging studies:

    1. 1- Brigham and Woman's Hospital, EEG reading, 30% effort

    Research Support, Commercial Entities:

    1. 1- UCB 2- Empatica 3- Biogen

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1- American Epilepsy Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Kyle R. Pellerin, BS,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Jin Jing, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Barbara A. Dworetzky, MD,
    6. Scientific Advisory Boards:

    1. Nonprofit research trial: Chair,DSMB for the The NIH study entitled The established status Epilepticus treatment trial (ESETT) that recently closed.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. non Profit: role as member of the Annals of Neurology Journal and ATN oversight committee, one hotel night paid for at last ANA meeting

    Editorial Boards:

    1. Epilepsy Currents, just completed 4 years on editorial board

    Patents:

    1. NONE

    Publishing Royalties:

    1. I get a very small amount of royalties from Oxford University Press for my book entitled: Psychogenic Nonepileptic Seizures: Toward the Integration of Care, 2017

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Digitrace, Consultant, eeg interpretation, commercial Best Doctors, Clinical Consultant, commercial

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Nonprofit, Professional advisory board for the epilepsy foundation of New England Board of Directors, American Epilepsy Society

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. site PI, the padsevonil trials, parexel/UCB

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Daniel B. Hoch, MD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Claire S. Jacobs, MD, PhD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Dr. Jacobs is an inventor on two patents related to the synthesis and use of DNA binding small molecules targeted to transcription factor binding sites: United States Patent US 7,935,530 B2. 2007 Nov 28; United States Patent US 9,630,950. 2017 Apr 25.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH/NINDS, R25NS065743, PI, 2017- 2019 (completed June 2019)

    Research Support, Academic Entities:

    1. (1) Massachusetts General Hospital, Department of Neurology funds

    Research Support, Foundations and Societies:

    1. (1) Bluefield Project to Cure FTD, (2) Philanthropic Support for CIC Precision Medicine

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Jong Woo Lee, MD, PhD,
    9. Scientific Advisory Boards:

    1. Nonprofit Investigation of silent mesial temporal lobe hyperexcitability in Alzheimer’s Disease Grant Number: NIA R21AG064413

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Epilepsy Currents, 2016-now

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Soterya Inc.: co-founder, scientific advisor

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) Advance Medical; contract work (2) DigiTrace; contract work

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH R01 NS062092; site PI NIH U01 NS098968; site PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Daniel S. Weisholtz, MD,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIMH, 1R21MH107820-01A1, co-investigator, 2018 (2) DARPA, W911NF-14-2-0045, co-investigator, 2018-2019 (3) NASA, NNX16A069A, co-investigator, 2019-2020 (4) NIH, 5R01NS062092-07, co-investigator, 2019-2020 (5) NIH, 5U01NS098968-03, co-investigator, 2019-2020

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. CVS, Expert witness for plaintiff.

  10. Rodrigo Zepeda, MD,
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. M. Brandon Westover, MD, PhD,
    12. Scientific Advisory Boards:

    1. (1) Scientific advisor for Beacon Biosignals, Inc.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Pocket Neurology, Lippincott Williams & Wilkins (2010). Pocket Neurology, 2nd Edition, Walters-Kluwer (2016).

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH (1R01NS102190, 1R01NS102574, 1R01NS107291)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. (1) Beacon Biosignals, Inc.

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Andrew J. Cole, MD and
    13. Scientific Advisory Boards:

    1. 1. Precisis AG 2. Medtronic 3. Sage Therapeutics

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Neuropace - Travel

    Editorial Boards:

    1. Associate Editor, Annals Clinical and Translational Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. UpToDate

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant to Sage Therepeutics, Precisis AG Pfizer Biogen Ovid

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Neuropace Stock/Stock Options, Medical Equipment & Materials: Precisis AG, 2013 Sage Pharmaceuticals, 2013

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Sydney S. Cash, MD, PhD
    14. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Funded as PI from NIH/NINDS R01-NS062092 Stock/Stock Options, Medical Equipment & Materials: Beacon Biosignals, 2019

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (A.D.L., K.R.P., J.J., D.B.H., C.S.J., M.B.W., A.J.C., S.S.C.), Massachusetts General Hospital; Department of Neurology (R.A.S., B.A.D., J.W.L., D.S.W.), Brigham and Women's Hospital, Boston, MA; and Department of Neurology and Neurotherapeutics (R.Z.), UT Southwestern Medical Center, Dallas, TX.
  1. Correspondence
    Dr. Lam Lam.Alice{at}mgh.harvard.edu
View Full Text

Article usage

Article usage: August 2020 to April 2023

AbstractFullPdfSource
Aug 2020939045Highwire
Sep 2020300022Highwire
Oct 2020143910392Highwire
Nov 20203143347Highwire
Dec 20202041619Highwire
Jan 20212623240Highwire
Feb 2021194721Highwire
Mar 20212402924Highwire
Apr 2021229936Highwire
May 2021208940Highwire
Jun 2021125614Highwire
Jul 20211241321Highwire
Aug 20211641336Highwire
Sep 20211811121Highwire
Oct 2021180925Highwire
Nov 20212171012Highwire
Dec 2021168912Highwire
Jan 202211495Highwire
Feb 202221629Highwire
Mar 2022165412Highwire
Apr 202220257Highwire
May 202210120Highwire
Jun 202212154Highwire
Jul 202213048Highwire
Aug 2022122115Highwire
Sep 202212112Highwire
Oct 202215344Highwire
Nov 20221121311Highwire
Dec 20225523Highwire
Jan 20237841Highwire
Feb 20238266Highwire
Mar 20238442Highwire
Apr 2023771611Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Topics Discussed

Alert Me

Recommended articles